Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
Lewallen, E.A., Jones, D.L., Dudakovic, A., Thaler, R., Paradise, C.R., Kremers, H.M., Abdel, M.P., Kakar, S., Dietz, A.B., Cohen, R.C., et al. (2016). Osteogenic potential of human adipose-tissue derived mesenchymal stromal cells cultured on 3D-printed porous structured titanium.Gene.
Lee, D.Joon, Park, Y., Hu, W.-S., and Ko, C.-C. (2016). Osteogenic Potential of Multipotent Adult Progenitor Cells for Calvaria Bone Regeneration.Adv Med2016, 2803081.
Lotz, E.M., Olivares-Navarrete, R., Berner, S., Boyan, B.D., and Schwartz, Z. (2016). Osteogenic Response of Human MSCs and Osteoblasts to Hydrophilic and Hydrophobic Nanostructured Titanium Implant Surfaces.J Biomed Mater Res A.
Li, W., Zheng, Y., Zhao, X., Ge, Y., Chen, T., Liu, Y., and Zhou, Y. (2016). Osteoinductive Effects of Free and Immobilized Bone Forming Peptide-1 on Human Adipose-Derived Stem Cells.Plos One11, e0150294.
Zhang, W., Zhang, X., Ling, J., Wei, X., and Jian, Y. (2016). Osteo-/odontogenic differentiation of BMP2 and VEGF gene-co-transfected human stem cells from apical papilla.Mol Med Rep.
Mahapatra, C., Singh, R.Kumar, Kim, J.-J., Patel, K.Dev, Perez, R.A., Jang, J.-H., and Kim, H.-W. (2016). Osteopromoting reservoir of stem cells: Bioactive mesoporous nanocarrier / collagen gel through slow-releasing FGF18 and the activated BMP signaling.Acs Appl Mater Interfaces.
Liu, X., Bao, C., Xu, H.H.K., Pan, J., Hu, J., Wang, P., and Luo, E. (2016). Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats.Acta Biomater.
Chen, J.C., and Christiano, A.M. (2016). Out of Many, One: Computational Reconstruction of Mouse Skin using Single-Cell Transcriptomics.Cell Stem Cell19, 421-422.
Robin, M., Porcher, R., Wolschke, C., de Fontbrune, F.Sicre, Alchalby, H., Christopeit, M., Cassinat, B., Zabelina, T., de Latour, R.Peffault, Ayuk, F., et al. (2016). Outcome after transplantation according to reduced intensity conditioning regimen in patients transplanted for myelofibrosis.Biol Blood Marrow Transplant.
Yun, S., Vincelette, N.D., Abraham, I., Puvvada, S., and Anwer, F. (2016). Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies.Acta Haematol136, 244-255.
Kobayashi, R., Mitsui, T., Fujita, N., Osumi, T., Aoki, T., Aoki, K., Suzuki, R., Fukuda, T., Miyamoto, T., Kato, K., et al. (2016). Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.Int J Hematol.
Pohlen, M., Groth, C., Sauer, T., Görlich, D., Mesters, R., Schliemann, C., Lenz, G., Müller-Tidow, C., Büchner, T., Berdel, W.E., et al. (2016). Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).Bone Marrow Transplant.
Franssen, L.E., Raymakers, R.A.P., Buijs, A., Schmitz, M.F., van Dorp, S., Mutis, T., Lokhorst, H.M., and van de Donk, N.W.C.J. (2016). Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution.Eur J Haematol.
Beauverd, Y., Roosnek, E., Tirefort, Y., Dantin, C., Ansari, M., Tsopra, O., Masouridi-Levrat, S., and Chalandon, Y. (2016). Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.Bone Marrow Transplant.
Koenecke, C., Heim, D., van Biezen, A., Heuser, M., Aljurf, M., Kyrcz-Krzemien, S., Volin, L., de Souza, C.A., Gedde-Dahl, T., Sengeloev, H., et al. (2016). Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.Bone Marrow Transplant.
Chandrakasan, S., Marsh, R.A., Uzel, G., Holland, S.M., Shah, K.N., and Bleesing, J. (2016). Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.J Allergy Clin Immunol.
Varma, A., Saliba, R.M., Torres, H.A., Afrough, A., Hosing, C., Khouri, I.F., Nieto, Y., Shah, N.D., Parmar, S., Bashir, Q., et al. (2016). Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.Bone Marrow Transplant.
Gaballa, S., Saliba, R.M., Srour, S., Lu, G., Brammer, J.E., Shah, N., Bashir, Q., Patel, K., Bock, F., Parmar, S., et al. (2016). Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.Am J Hematol.
Van Den Neste, E., Schmitz, N., Mounier, N., Gill, D., Linch, D., Trneny, M., Bouadballah, R., Radford, J., Bargetzi, M., Ribrag, V., et al. (2016). Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.Bone Marrow Transplant.
Kourelis, T.V., Nasr, S.H., Dispenzieri, A., Kumar, S.K., Gertz, M.A., Fervenza, F.C., Buadi, F.K., Lacy, M.Q., Erickson, S.B., Cosio, F.G., et al. (2016). Outcomes of patients with renal monoclonal immunoglobulin deposition disease.Am J Hematol.
Jain, A.K., and Barton, M.C. (2016). Outside the p53 RING: Transcription Regulation by Chromatin-Bound MDM2.Mol Cell62, 805-807.
Truman, A.M., Tilly, J.L., and Woods, D.C. (2016). Ovarian regeneration: The potential for stem cell contribution in the postnatal ovary to sustained endocrine function.Mol Cell Endocrinol.
Lu, K.-T., Wang, B.-Y., Chi, W.-Y., Chang-Chien, J., Yang, J.-J., Lee, H.-T., Tzeng, Y.-M., and Chang, W.-W. (2016). Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27.Toxins (Basel)8.
Panula, S., Reda, A., Stukenborg, J.-B., Ramathal, C., Sukhwani, M., Albalushi, H., Edsgärd, D., Nakamura, M., Söder, O., Orwig, K.E., et al. (2016). Over Expression of NANOS3 and DAZL in Human Embryonic Stem Cells.Plos One11, e0165268.
Rini, B.I., Tomita, Y., Melichar, B., Ueda, T., Grünwald, V., Fishman, M.N., Uemura, H., Oya, M., Bair, A.H., Andrews, G.I., et al. (2016). Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma.Clin Genitourin Cancer.